Eikon Therapeutics, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| – | – | – | |
| – | +43.1% | -4.8% | |
| – | +30.3% | +45.1% | |
| – | +708.4% | -3.5% | |
| – | +197.4% | -44.9% | |
| – | – | – | |
| – | -99.8% | +144,184.0% | |
| – | -67.6% | -206.0% | |
| – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.